• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血清分析物的判别函数可区分肝癌与继发性肝肿瘤。

Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia.

作者信息

Castaldo G, Oriani G, Cimino L, Topa M, Budillon G, Salvatore F, Sacchetti L

机构信息

Dipartimento di Biochimica e Biotecnologie Mediche, Facoltà di Medicina e Chirurgia, Università di Napoli Federico II, Italy.

出版信息

Clin Chem. 1995 Mar;41(3):439-43.

PMID:7533673
Abstract

Hepatocellular carcinoma (HC) is often difficult to distinguish from secondary liver neoplasia (SLN) by physical and imaging diagnostic procedures alone. To this aim we have extended and improved a laboratory approach based on a serum lactate dehydrogenase isoenzyme ratio (LD4:LD5) by adding the carcinoembryonic antigen: alpha-fetoprotein ratio, alkaline phosphatase, and serum iron concentrations to obtain a highly efficient discriminant function. In two successive cohorts, for a total of 102 patients, all histologically diagnosed, with a prevalence of HC vs SLN of 3:1, we correctly classified 96% of cases (100% of SLN cases). Subsequent verification with the jackknife reallocation statistical algorithm confirmed these results. In conclusion, this discriminant function based on simple laboratory assays of a few analytes is an important tool in solving a diagnostic dilemma in cases of liver neoplasia.

摘要

仅通过体格检查和影像学诊断程序,肝细胞癌(HC)往往很难与继发性肝肿瘤(SLN)区分开来。为此,我们扩展并改进了一种基于血清乳酸脱氢酶同工酶比率(LD4:LD5)的实验室方法,加入癌胚抗原与甲胎蛋白的比率、碱性磷酸酶和血清铁浓度,以获得一种高效的判别函数。在两个连续队列中,共有102例经组织学确诊的患者,HC与SLN的患病率为3:1,我们正确分类了96%的病例(100%的SLN病例)。随后用留一法重新分配统计算法进行验证,证实了这些结果。总之,这种基于对几种分析物进行简单实验室检测的判别函数,是解决肝肿瘤病例诊断难题的重要工具。

相似文献

1
Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia.基于血清分析物的判别函数可区分肝癌与继发性肝肿瘤。
Clin Chem. 1995 Mar;41(3):439-43.
2
Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes.通过基于血清分析物结果的判别函数对肝细胞癌和肝硬化进行鉴别诊断。
Clin Chem. 1996 Aug;42(8 Pt 1):1263-9.
3
Serum lactate dehydrogenase isoenzyme 4/5 ratio discriminates between hepatocarcinoma and secondary liver neoplasia.血清乳酸脱氢酶同工酶4/5比值可区分肝癌与继发性肝肿瘤。
Clin Chem. 1991 Aug;37(8):1419-23.
4
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma].[胃癌中的癌胚抗原、甲胎蛋白及肝癌碱性磷酸酶]
Gan No Rinsho. 1988 Feb;34(2):208-12.
5
Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.肝脏疾病评估中的诊断程序。功能评估:癌胚抗原(CEA)和甲胎蛋白(AFP)作为肝脏肿瘤标志物。
Lab Res Methods Biol Med. 1983;7:153-7.
6
[Biochemical markers in the neoplasms of the liver, biliary tract and pancreas].[肝脏、胆道和胰腺肿瘤中的生化标志物]
Nihon Rinsho. 1982;40(1):43-50.
7
[Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].基于血清分析物的原发性肝癌诊断判别函数
Hunan Yi Ke Da Xue Xue Bao. 2000 Aug 28;25(4):373-5.
8
Serum lactate dehydrogenase isoenzymes in patients with hepatocellular carcinoma.肝细胞癌患者的血清乳酸脱氢酶同工酶
Taiwan Yi Xue Hui Za Zhi. 1982 Feb;81(2):218-23.
9
Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.甘氨酰脯氨酸二肽氨基肽酶同工酶在原发性肝细胞癌诊断中的应用
World J Gastroenterol. 2003 Apr;9(4):710-3. doi: 10.3748/wjg.v9.i4.710.
10
A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.甲胎蛋白与p53抗体在肝细胞癌诊断中的比较。
Transplant Proc. 1998 May;30(3):780-1. doi: 10.1016/s0041-1345(98)00045-1.

引用本文的文献

1
HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.HCC-ART 评分:一种用于早期诊断肝细胞癌的简单、高敏感、高特异的检测方法:一项大规模、多中心研究。
Br J Cancer. 2013 Sep 17;109(6):1657-65. doi: 10.1038/bjc.2013.481. Epub 2013 Aug 27.